Engineering of siRNA loaded PLGA Nano-Particles for highly efficient silencing of GPR87 gene as a target for pancreatic cancer treatment

References

• Bahadori F, Büyük AŞ, Kozanoğlu AS, Eskandari Z, Ankarali H, Tekkeli ŞEK, Kaleli HN, Koçyiğit A. 2019. Preparation and evaluation of inflammation targeted nano-micellar formulation of celecoxib. Bezmialem Sci. 7(3):208–215.
   Web of Science ®Google Scholar
• Bannunah AM, Vllasaliu D, Lord J, Stolnik S. 2014. Mechanisms of nanoparticle internalization and transport across an intestinal epithelial cell model: effect of size and surface charge. Mol Pharm. 11(12):4363–4373.
   PubMed Web of Science ®Google Scholar
• Bhandari J, Mishra H, Mishra PK, Wimmer R, Ahmad FJ, Talegaonkar S. 2017. Cellulose nanofiber aerogel as a promising biomaterial for customized oral drug delivery. IJN. 12:2021–2031.
   Google Scholar
• Chan JM, Zhang L, Yuet KP, Liao G, Rhee J-W, Langer R, Farokhzad OC. 2009. PLGA–lecithin–PEG core–shell nanoparticles for controlled drug delivery. Biomaterials. 30(8):1627–1634.
   PubMed Web of Science ®Google Scholar
• Chithrani BD, Ghazani AA, Chan WC. 2006. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 6(4):662–668.
   PubMed Web of Science ®Google Scholar
• Colombo S, Zeng X, Ragelle H, Foged C. 2014. Complexity in the therapeutic delivery of RNAi medicines: an analytical challenge. Expert Opin Drug Deliv. 11(9):1481–1495.
   PubMed Web of Science ®Google Scholar
• Cun D, Foged C, Yang M, Frøkjaer S, Nielsen HM. 2010. Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery. Int J Pharm. 390(1):70–75.
   PubMedGoogle Scholar
• Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Préat V. 2012. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release. 161(2):505–522.
   PubMed Web of Science ®Google Scholar
• Danhier F, Feron O, Préat V. 2010. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release. 148(2):135–146.
   PubMed Web of Science ®Google Scholar
• Eskandari Z, Kazdal F, Bahadori F, Ebrahimi N. 2018. Quality-by-design model in optimization of PEG-PLGA nano micelles for targeted cancer therapy. J Drug Delivery Sci Technol. 48:393–402.
   Web of Science ®Google Scholar
• Furler M, Knobloch B, Sigel RK. 2009. Influence of decreased solvent permittivity on the structure and magnesium (II)-binding properties of the catalytic domain 5 of a group II intron ribozyme. Inorg Chim Acta. 362(3):771–776.
   Web of Science ®Google Scholar
• Garcia F, Petry KU, Muderspach L, Gold MA, Braly P, Crum CP, Magill M, Silverman M, Urban RG, Hedley ML. 2004. ZYC101a for treatment of high-grade cervical intraepithelial neoplasia: a randomized controlled trial. Obstet Gynecol. 103(2):317–326.
   PubMed Web of Science ®Google Scholar
• Gary DJ, Puri N, Won Y-Y. 2007. Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery. J Control Release. 121(1–2):64–73.
   PubMed Web of Science ®Google Scholar
• Glatt S, Halbauer D, Heindl S, Wernitznig A, Kozina D, Su KC, Puri C, Garin‐Chesa P, Sommergruber W. 2008. hGPR87 contributes to viability of human tumor cells. Int J Cancer. 122(9):2008–2016.
   PubMed Web of Science ®Google Scholar
• Hasan W, Chu K, Gullapalli A, Dunn SS, Enlow EM, Luft JC, Tian S, Napier ME, Pohlhaus PD, Rolland JP, et al. 2012. Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer. Nano Lett. 12(1):287–292.
   PubMed Web of Science ®Google Scholar
• Honary S, Zahir F. 2013. Effect of zeta potential on the properties of nano-drug delivery systems-a review (Part 2). Trop J Pharm Res. 12(2):265–273.
   Google Scholar
• Howard KA. 2009. Delivery of RNA interference therapeutics using polycation-based nanoparticles. Adv Drug Delivery Rev. 61(9):710–720.
   PubMed Web of Science ®Google Scholar
• Klencke B, Matijevic M, Urban RG, Lathey JL, Hedley ML, Berry M, Thatcher J, Weinberg V, Wilson J, Darragh T, et al. 2002. Encapsulated plasmid DNA treatment for human papillomavirus 16-associated anal dysplasia: a Phase I study of ZYC101. Clin Cancer Res. 8(5):1028–1037.
   PubMed Web of Science ®Google Scholar
• Lee J-S, Green JJ, Love KT, Sunshine J, Langer R, Anderson DG. 2009. Gold, poly (β-amino ester) nanoparticles for small interfering RNA delivery. Nano Lett. 9(6):2402–2406.
   PubMed Web of Science ®Google Scholar
• Lee SH, Mok H, Lee Y, Park TG. 2011. Self-assembled siRNA-PLGA conjugate micelles for gene silencing. J Control Release. 152(1):152–158.
   PubMed Web of Science ®Google Scholar
• Liang GF, Zhu YL, Sun B, Hu FH, Tian T, Li SC, Xiao ZD. 2011. PLGA-based gene delivering nanoparticle enhance suppression effect of miRNA in HePG2 cells. Nanoscale Res Lett. 6(1):447.
   PubMedGoogle Scholar
• Lindfors L, Skantze P, Skantze U, Westergren J, Olsson U. 2007. Amorphous drug nanosuspensions. 3. Particle dissolution and crystal growth. Langmuir. 23(19):9866–9874.
   PubMed Web of Science ®Google Scholar
• Luo G, Jin C, Long J, Fu D, Yang F, Xu J, Yu X, Chen W, Ni Q. 2009. RNA interference of MBD1 in BxPC-3 human pancreatic cancer cells delivered by PLGA-poloxamer nanoparticles. Cancer Biol Ther. 8(7):594–598.
   PubMed Web of Science ®Google Scholar
• Maeda H. 2012. Macromolecular therapeutics in cancer treatment: the EPR effect and beyond. J Control Release. 164(2):138–144.
   PubMed Web of Science ®Google Scholar
• Muro S, Garnacho C, Champion JA, Leferovich J, Gajewski C, Schuchman EH, Mitragotri S, Muzykantov VR. 2008. Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. Mol Ther. 16(8):1450–1458.
   PubMed Web of Science ®Google Scholar
• Nakano S-I, Sugimoto N. 2016. The structural stability and catalytic activity of DNA and RNA oligonucleotides in the presence of organic solvents. Biophys Rev. 8(1):11–23.
   PubMedGoogle Scholar
• Nakano S-I, Wu L, Oka H, Karimata HT, Kirihata T, Sato Y, Fujii S, Sakai H, Kuwahara M, Sawai H, et al. 2008. Conformation and the sodium ion condensation on DNA and RNA structures in the presence of a neutral cosolute as a mimic of the intracellular media. Mol Biosyst. 4(6):579–588.
   PubMedGoogle Scholar
• Pantazis P, Dimas K, Wyche JH, Anant S, Houchen CW, Panyam J, Ramanujam RP. 2012. Preparation of siRNA-encapsulated PLGA nanoparticles for sustained release of siRNA and evaluation of encapsulation efficiency. Methods Mol Biol. 906:311–319.
   PubMedGoogle Scholar
• Patil ML, Zhang M, Minko T. 2011. Multifunctional triblock nanocarrier (PAMAM-PEG-PLL) for the efficient intracellular siRNA delivery and gene silencing. ACS Nano. 5(3):1877–1887.
   PubMed Web of Science ®Google Scholar
• Patil Y, Panyam J. 2009. Polymeric nanoparticles for siRNA delivery and gene silencing. Int J Pharm. 367(1–2):195–203.
   PubMed Web of Science ®Google Scholar
• Pereira MC, Oliveira DA, Hill LE, Zambiazi RC, Borges CD, Vizzotto M, Mertens-Talcott S, Talcott S, Gomes CL. 2018. Effect of nanoencapsulation using PLGA on antioxidant and antimicrobial activities of guabiroba fruit phenolic extract. Food Chem. 240:396–404.
   PubMed Web of Science ®Google Scholar
• Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. 2014. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 74(11):2913–2921.
   PubMed Web of Science ®Google Scholar
• Shi J, Xiao Z, Votruba AR, Vilos C, Farokhzad OC. 2011. Differentially charged hollow core/shell lipid–polymer–lipid hybrid nanoparticles for small interfering RNA delivery. Angew Chem Int Ed Engl. 50(31):7027–7031.
   PubMed Web of Science ®Google Scholar
• Shu D, Shu Y, Haque F, Abdelmawla S, Guo P. 2011. Thermodynamically stable RNA three-way junction for constructing multifunctional nanoparticles for delivery of therapeutics. Nat Nanotechnol. 6(10):658–667.
   PubMed Web of Science ®Google Scholar
• Türeli NG, Türeli AE, Schneider M. 2016. Optimization of ciprofloxacin complex loaded PLGA nanoparticles for pulmonary treatment of cystic fibrosis infections: design of experiments approach. Int J Pharm. 515(1–2):343–351.
   PubMed Web of Science ®Google Scholar
• Vichai V, Kirtikara K. 2006. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 1(3):1112–1116.
   PubMed Web of Science ®Google Scholar
• Vijayanathan V, Thomas T, Thomas T. 2002. DNA nanoparticles and development of DNA delivery vehicles for gene therapy. Biochemistry. 41(48):14085–14094.
   PubMed Web of Science ®Google Scholar
• Wang J, Lu Z, Wientjes MG, Au J-S. 2010. Delivery of siRNA therapeutics: barriers and carriers. Aaps J. 12(4):492–503.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhou W, Zhong Y, Huo Y, Fan P, Zhan S, Xiao J, Jin X, Gou S, Yin T, et al. 2017. Overexpression of G protein-coupled receptor GPR87 promotes pancreatic cancer aggressiveness and activates NF-κB signaling pathway. Mol Cancer. 16(1):61.
   PubMedGoogle Scholar
• Wilson RC, Doudna JA. 2013. Molecular mechanisms of RNA interference. Annu Rev Biophys. 42(1):217–239.
   PubMedGoogle Scholar
• Wise DL. 2000. Handbook of pharmaceutical controlled release technology. Boca Raton (FL): CRC Press.
   Google Scholar
• Wittenberger T, Schaller HC, Hellebrand S. 2001. An expressed sequence tag (EST) data mining strategy succeeding in the discovery of new G-protein coupled receptors. J Mol Biol. 307(3):799–813.
   PubMed Web of Science ®Google Scholar
• Yuan X, Shah BA, Kotadia NK, Li J, Gu H, Wu Z. 2010. The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery. Pharm Res. 27(7):1285–1295.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Qian Y, Lu W, Chen X. 2009. The G protein-coupled receptor 87 is necessary for p53-dependent cell survival in response to genotoxic stress. Cancer Res. 69(15):6049–6056.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Scoumanne A, Chen X. 2010. G protein-coupled receptor 87: a promising opportunity for cancer drug discovery. Mol Cell Pharmacol. 2(3):111–116.
   PubMedGoogle Scholar
• Zottel A, Videtič Paska A, Jovčevska I. 2019. Nanotechnology meets oncology: nanomaterials in brain cancer research, diagnosis and therapy. Materials (Basel). 12(10):1588. eng.
   Web of Science ®Google Scholar